These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16330221)

  • 21. The 6th world meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology (PBP meeting) April 7-10, 2008, Barcelona, Spain.
    Kleinebudde P; Alex R; Fattal E; Göpferich A; Siepmann J
    AAPS PharmSciTech; 2008; 9(3):828. PubMed ID: 18618267
    [No Abstract]   [Full Text] [Related]  

  • 22. An integrated early formulation strategy--from hit evaluation to preclinical candidate profiling.
    Maas J; Kamm W; Hauck G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):1-10. PubMed ID: 17123801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approach to assay validation for the development of biopharmaceuticals.
    Lundblad RL
    Biotechnol Appl Biochem; 2001 Dec; 34(3):195-7. PubMed ID: 11785468
    [No Abstract]   [Full Text] [Related]  

  • 24. Manufacturing of biopharmaceuticals and implications for biosimilars.
    Wurm FM
    Kidney Blood Press Res; 2007; 30 Suppl 1():6-8. PubMed ID: 17726336
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study designs for the evaluation of drug effects].
    Christensen S; Christiansen CF; Sørensen HT
    Ugeskr Laeger; 2009 Mar; 171(10):799-802. PubMed ID: 19265605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatography-free recovery of biopharmaceuticals through aqueous two-phase processing.
    Azevedo AM; Rosa PA; Ferreira IF; Aires-Barros MR
    Trends Biotechnol; 2009 Apr; 27(4):240-7. PubMed ID: 19251328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How many traditional Chinese medicine components have been recognized by modern Western medicine? A chemoinformatic analysis and implications for finding multicomponent drugs.
    Kong DX; Li XJ; Tang GY; Zhang HY
    ChemMedChem; 2008 Feb; 3(2):233-6. PubMed ID: 18022980
    [No Abstract]   [Full Text] [Related]  

  • 28. Editorial: Chemical equivalence & clinical inequality.
    Ceylon Med J; 1972 Sep; 17(3):121-2. PubMed ID: 4667775
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pharmacopeia and preparations for cutaneous application].
    Esnault F; Etchegaray JP; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial: An incident in Pyongyang.
    JAMA; 1973 Dec; 226(12):1461. PubMed ID: 4800814
    [No Abstract]   [Full Text] [Related]  

  • 31. APhA and APS collaborate. Recommendation to HEW on multi-source drug list.
    Busse LW
    J Am Pharm Assoc; 1974 Oct; 14(10):556-7. PubMed ID: 4417005
    [No Abstract]   [Full Text] [Related]  

  • 32. Do we need highly sensitive analytical techniques in phase I?
    Singlas E
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():135s-140s. PubMed ID: 2093624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BIOPHARMACEUTICS influence of formulation on THERAPEUTIC ACTIVITY 1. DEFINITIONS, SCOPE and relationship to GASTROINTESTINAL PHYSIOLOGY.
    Wagner JG
    Ann Pharmacother; 2006 Mar; 40(3):537-41. PubMed ID: 16507610
    [No Abstract]   [Full Text] [Related]  

  • 34. A note on the conservativeness of the confidence interval approach for the selection of non-inferiority margin in the two-arm active-control trial.
    Sankoh AJ
    Stat Med; 2008 Aug; 27(19):3732-42. PubMed ID: 18407575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A regulatory perspective on issues and approaches in characterizing human metabolites.
    Davis-Bruno KL; Atrakchi A
    Chem Res Toxicol; 2006 Dec; 19(12):1561-3. PubMed ID: 17173368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanosizing--oral formulation development and biopharmaceutical evaluation.
    Kesisoglou F; Panmai S; Wu Y
    Adv Drug Deliv Rev; 2007 Jul; 59(7):631-44. PubMed ID: 17601629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studying drug-plasma protein interactions by two-injector microchip electrophoresis frontal analysis.
    Liu X; Liang A; Shen Z; Liu X; Zhang Y; Dai Z; Xiong B; Lin B
    Electrophoresis; 2006 Dec; 27(24):5128-31. PubMed ID: 17117388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HTS technologies in biopharmaceutical discovery.
    Wu G; Doberstein SK
    Drug Discov Today; 2006 Aug; 11(15-16):718-24. PubMed ID: 16846799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current problems in the quality controll of pharmaceutical preparations manufactured in pharmacies I. Identification tests].
    Horváth P; Elekné Vörös Z; Sinkó B; Vámos J; Takácsné Novák K
    Acta Pharm Hung; 2006; 76(2):86-94. PubMed ID: 17094667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generic equivalence or non-equivalence, or "few facts and much fancy".
    Wolff F
    Dis Chest; 1969 Jul; 56(1):3. PubMed ID: 5789838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.